1. Home
  2. AAT vs AVLN Comparison

AAT vs AVLN Comparison

Compare AAT & AVLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo American Assets Trust Inc.

AAT

American Assets Trust Inc.

HOLD

Current Price

$24.30

Market Cap

1.5B

Sector

Real Estate

ML Signal

HOLD

Logo Avalyn Pharma Inc. Common Stock

AVLN

Avalyn Pharma Inc. Common Stock

N/A

Current Price

$27.95

Market Cap

1.3B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
AAT
AVLN
Founded
1967
N/A
Country
United States
United States
Employees
208
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
1.3B
IPO Year
2010
2026

Fundamental Metrics

Financial Performance
Metric
AAT
AVLN
Price
$24.30
$27.95
Analyst Decision
Sell
Analyst Count
2
0
Target Price
$19.50
N/A
AVG Volume (30 Days)
367.5K
413.8K
Earning Date
04-28-2026
N/A
Dividend Yield
6.65%
N/A
EPS Growth
N/A
N/A
EPS
0.08
N/A
Revenue
$436,204,000.00
N/A
Revenue This Year
$4.33
N/A
Revenue Next Year
$0.22
N/A
P/E Ratio
$303.00
N/A
Revenue Growth
N/A
N/A
52 Week Low
$17.72
$24.90
52 Week High
$25.97
$33.32

Technical Indicators

Market Signals
Indicator
AAT
AVLN
Relative Strength Index (RSI) 44.43 41.88
Support Level $23.69 $27.22
Resistance Level $24.85 $29.59
Average True Range (ATR) 0.49 1.94
MACD -0.21 0.21
Stochastic Oscillator 15.31 62.25

Price Performance

Historical Comparison
AAT
AVLN

About AAT American Assets Trust Inc.

American Assets Trust Inc is a self-administered real estate investment trust based in the United States. The company invests in, operates, and develops retail, office, residential, and mixed-use properties. Properties are predominantly located in South California, Northern California, Oregon, Washington, and Hawaii. American Assets operates through four segments based on property type: retail; office; mixed-use, which consists of retail and hotel components; and multifamily, which includes the company's apartment properties. The retail and office segments collectively contribute the majority of the total revenue.

About AVLN Avalyn Pharma Inc. Common Stock

Avalyn Pharma Inc is a clinical-stage biopharmaceutical company developing inhaled medicines to treat rare respiratory diseases, including pulmonary fibrosis and other interstitial lung diseases (ILDs). Its current pipeline is focused on treating pulmonary fibrosis, a life-threatening disease with a median survival of three to five years, which is a significantly shorter prognosis than that observed for many forms of cancer. Its flagship programs include AP01 and AP02, which are inhaled formulations of pirfenidone and nintedanib being developed for conditions such as progressive pulmonary fibrosis and idiopathic pulmonary fibrosis. The company has one operating and reportable segment, which is the business of developing and commercializing targeted therapies for rare lung diseases.

Share on Social Networks: